Mazabraud Yann

EVP, Head of InternationalRHYTHM PHARMACEUTICALS, INC. (RYTM) · full profile →Form 4 · filed Aug 14, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.6M
Net Open-Market Flow
-$6.6M
Transactions
8
7 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 12, 2026Option exercise(M)47K$6.80$317K113K
Aug 12, 2026Sell(S)2K$111.80$257K110K
Aug 12, 2026Sell(S)1K$112.86$113K109K
Aug 12, 2026Sell(S)4K$114.70$413K106K
Aug 12, 2026Sell(S)15K$115.43$1.7M91K
Aug 12, 2026Sell(S)18K$116.49$2.1M73K
Aug 12, 2026Sell(S)17K$117.47$2.0M56K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 12, 2026Option exercise(M)47K$036K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001649904-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about RYTM insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001649904-26-000007"
Ask your agent
Use Arkolith to summarize insider buying and selling at RHYTHM PHARMACEUTICALS, INC.
over the last 90 days and cite the filings.